Beneficial and detrimental effects of natural dietary products on the risk of hepatocellular carcinoma, and their roles in its management

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Hepatoma Research

• Publication date

  2016-03-09

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.20517/2394-5079.2015.64
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of natural compounds in treatment and prevention of hepatotoxicity and hepatocellular carcinoma

  2015cited by this paper
• Hepatotoxicity of Pyrrolizidine Alkaloids.

  2015cited by this paper
• Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.

  2015cited by this paper
• Carcinogenicity of consumption of red and processed meat.

  2015cited by this paper
• Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort.

  2015cited by this paper
• Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study

  2015influential reference
• Dietary mycotoxins, co-exposure, and carcinogenesis in humans: Short review.

  2015cited by this paper
• Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell line.

  2015cited by this paper
• Dietary supplementation in cancer patients: a personal view of current status and future perspectives.

  2014cited by this paper
• Determination of pyrrolizidine alkaloids in tea, herbal drugs and honey

  2014cited by this paper
• [A case-control study on the risk factors of hepatocellular carcinoma in Guizhou Province].

  2014cited by this paper
• The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma

  2014cited by this paper
• Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways.

  2014influential reference
• Exposure assessment to mycotoxins in gluten-free diet for celiac patients.

  2014cited by this paper
• The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study

  2014cited by this paper
• Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].

  2014cited by this paper
• TOPIC HIGHLIGHT

  2014cited by this paper
• Mediterranean diet and hepatocellular carcinoma.

  2014cited by this paper
• Olea europaea Linn. Fruit Pulp Extract Protects against Carbon Tetrachloride-induced Hepatic Damage in Mice

  2014cited by this paper
• Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC).

  2013cited by this paper
• Hepatocellular carcinoma and food contamination: aflatoxins and ochratoxin A as a great prompter.

  2013influential reference
• Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention

  2013cited by this paper
• Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans.

  2013influential reference
• Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?

  2013cited by this paper
• Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma.

  2013cited by this paper
• Chemopreventive and Therapeutic Potential of Tea Polyphenols in Hepatocellular Cancer

  2013cited by this paper
• Protective effect of Spirulina platensis enriched in phenolic compounds against hepatotoxicity induced by CCl4.

  2013cited by this paper
• Case Report Evidence of Relationships between Hepatocellular Carcinoma and Ochratoxicosis

  2013cited by this paper
• Is it time to write a prescription for coffee? Coffee and liver disease.

  2013cited by this paper
• Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis

  2013cited by this paper
• Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.

  2013cited by this paper
• Mycotoxins: occurrence, toxicology, and exposure assessment.

  2013cited by this paper
• Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.

  2013cited by this paper
• Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial

  2012cited by this paper
• Pickled Food and Risk of Gastric Cancer—a Systematic Review and Meta-analysis of English and Chinese Literature

  2012cited by this paper
• Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma.

  2012cited by this paper
• An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity.

  2012cited by this paper
• Antiproliferative, antioxidant and anti-inflammatory effects of hydroxytyrosol on human hepatoma HepG2 and Hep3B cell lines.

  2012cited by this paper
• Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

  2012cited by this paper
• Occurrence of fumonisins in Catalonia (Spain) and an exposure assessment of specific population groups

  2012cited by this paper
• Time course of DNA adduct formation in peripheral blood granulocytes and lymphocytes after drinking alcohol.

  2012cited by this paper
• Hepatocellular carcinoma and vitamin D: A review

  2011cited by this paper
• Silymarin use and liver disease progression in the Hepatitis C Antiviral Long‐Term Treatment against Cirrhosis trial

  2011cited by this paper
• Oral Branched-Chain Amino Acid Granules Reduce the Incidence of Hepatocellular Carcinoma and Improve Event-Free Survival in Patients with Liver Cirrhosis

  2011cited by this paper
• Nutritional aspects in patient undergoing liver resection

  2011cited by this paper
• Pyrrolizidine alkaloids in food: a spectrum of potential health consequences

  2011cited by this paper
• Branched‐chain amino acids as pharmacological nutrients in chronic liver disease

  2011cited by this paper
• Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology.

  2011cited by this paper
• Role of TLR4 in ethanol effects on innate and adaptive immune responses in peritoneal macrophages

  2011cited by this paper
• Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort.

  2010influential reference
• Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment

  2010cited by this paper
• Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

  2010influential reference
• Effect of an oral branched chain amino acid‐enriched snack in cirrhotic patients with sleep disturbance

  2010cited by this paper
• MicroRNAs: master regulators of ethanol abuse and toxicity?

  2010cited by this paper
• Dietary glycemic load and hepatocellular carcinoma with or without chronic hepatitis infection.

  2009cited by this paper
• Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2

  2009influential reference
• Glycemic load in relation to hepatocellular carcinoma among patients with chronic hepatitis infection.

  2009cited by this paper
• Effects of the Mediterranean diet on longevity and age-related morbid conditions.

  2009cited by this paper
• Methods for assessing intrahepatic fat content and steatosis

  2009cited by this paper
• Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma.

  2009influential reference
• Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice.

  2008cited by this paper
• Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms.

  2008cited by this paper
• [Long time oral supplementation with branched-chain amino acids improves survival and decreases recurrences in patients with hepatocellular carcinoma].

  2008cited by this paper
• Glutathione treatment of hepatocellular carcinoma.

  2008cited by this paper
• Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.

  2007cited by this paper
• B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer

  2007cited by this paper
• Combination of N‐acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non‐alcoholic steatohepatitis

  2007cited by this paper
• Coffee consumption and risk of liver cancer: a meta-analysis.

  2007cited by this paper
• Active components and clinical applications of olive oil.

  2007cited by this paper
• Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China

  2007cited by this paper
• Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.

  2006cited by this paper
• Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

  2005cited by this paper
• Silibinin Efficacy against Human Hepatocellular Carcinoma

  2005cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms.

  2004cited by this paper
• Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

  2004cited by this paper
• Obesity and hepatocellular carcinoma.

  2004cited by this paper
• Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets.

  2003cited by this paper
• Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

  2003cited by this paper
• Vegetables and fruit intake and cancer mortality in the Hiroshima/Nagasaki Life Span Study

  2003cited by this paper
• The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

  2003cited by this paper
• Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

  2002cited by this paper
• The toxicology of aflatoxins as a basis for public health decisions.

  2002cited by this paper
• Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

  2002cited by this paper
• Does coffee protect against hepatocellular carcinoma?

  2002cited by this paper
• Antioxidant and other biological activities of phenols from olives and olive oil

  2002cited by this paper
• Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice.

  2001cited by this paper
• Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes

  2001cited by this paper
• Rat Kidney Pathology Induced by Chronic Exposure to Fumonisin B1 Includes Rare Variants of Renal Tubule Tumor

  2001cited by this paper
• Role of diabetes mellitus in the etiology of hepatocellular carcinoma.

  2000cited by this paper
• Early Feeding or Enteral Nutrition in Patients with Cirrhosis After Bleeding from Esophageal Varices? (A Randomized Controlled Study)

  1997cited by this paper
• Fumonisins as a possible contributory risk factor for primary liver cancer: a 3-year study of corn harvested in Haimen, China, by HPLC and ELISA.

  1997cited by this paper
• Accelerated improvement of alcoholic liver disease with enteral nutrition.

  1992cited by this paper
• [The use of reduced glutathione in alcoholic hepatopathy].

  1991cited by this paper
• Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats.

  1991cited by this paper
• Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

  1991cited by this paper
• Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial.

  1990cited by this paper
• Promoting effect of Roussin's red identified in pickled vegetables from Linxian China.

  1981cited by this paper
• Primary carcinoma of the liver in Ethiopia. A study of 38 cases proved at post-mortem examination.

  1970cited by this paper
• The hepatotoxicity of some Ethiopian and East African plants, including some used in traditional medicines.

  1968cited by this paper

• Micronutrient Food Supplements in Patients with Gastro-Intestinal and Hepatic Cancers

  2021cites this paper